Zurcher Kantonalbank (Zurich Cantonalbank) Day One Biopharmaceuticals, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $34.1 Billion
- Q4 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 14,269 shares of DAWN stock, worth $171,941. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,269
Previous 6,978
104.49%
Holding current value
$171,941
Previous $97,000
85.57%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DAWN
# of Institutions
180Shares Held
84MCall Options Held
148KPut Options Held
218K-
Ra Capital Management, L.P. Boston, MA7.87MShares$94.9 Million1.53% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$77.5 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$70.9 Million0.0% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$58.7 Million1.92% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$54.6 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $885M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...